Selenium suppresses leukemia through the action of endogenous eicosanoids.
Selenium suppresses leukemia through the action of endogenous eicosanoids.
复制标题
DOI:
10.1158/0008-5472.can-13-3694
复制
发表时间:
2014-07-15
期刊:
影响因子:
11.2
通讯作者:
Prabhu KS
中科院分区:
文献类型:
--
作者:
Gandhi UH;Kaushal N;Hegde S;Finch ER;Kudva AK;Kennett MJ;Jordan CT;Paulson RF;Prabhu KS
Eradicating cancer stem-like cells (CSC) may be essential to fully eradicate cancer. Metabolic changes in CSC could hold a key to their targeting. Here we report that the dietary micronutrient selenium can trigger apoptosis of CSC derived from chronic or acute myelogenous leukemias when administered at supraphysiological but non-toxic doses. In leukemia CSC, selenium treatment activated ATM-p53-dependent apoptosis accompanied by increased intracellular levels of reactive oxygen species. Importantly, the same treatment did not trigger apoptosis in hematopoietic stem cells. Serial transplantation studies with BCR-ABL-expressing CSC revealed that the selenium status in mice was a key determinant of CSC survival. Selenium action relied upon the endogenous production of the cyclooxygenase-derived prostaglandins Δ12-PGJ2 and 15d-PGJ2. Accordingly, non-steroidal anti-inflammatory drugs and NADPH oxidase inhibitors abrogated the ability of selenium to trigger apoptosis in leukemia CSC. Our results reveal how selenium-dependent modulation of arachidonic acid metabolism can be directed to trigger apoptosis of primary human and murine CSC in leukemia.